Disruptive Pharma AB

Spotlight on Peter Åsberg, CEO of Disruptive Pharma AB Peter Åsberg brings much more to the table than his title of CEO at Disruptive Pharma AB might suggest. With a Ph.D. in Applied Biochemistry and Physics from Linköping University and two decades of high-level experience in pharmaceuticals and biotech, Peter is well-equipped to lead. But what makes him truly stand out isn’t just his impressive resume; it’s his insatiable curiosity and his multi-faceted approach to both work and life. At Disruptive Pharma, Peter has been at the helm since 2021, working to bring innovative drug solutions to market through Mesoporous Magnesium Carbonate technology. This cutting-edge platform, which enhances drug solubility and stabilizes amorphous APIs, is reshaping the landscape for safer and more effective treatments. But Peter’s vision doesn’t stop with technology—he’s a people-focused leader who thrives on building partnerships that benefit both the company and the healthcare field at large. Outside work, Peter is the kind of person you’d want to sit down and have a long conversation with. He’s an avid traveler who’s explored nearly every corner of the globe, picking up bits of new languages along the way. He’s always up for a challenge, whether it’s skiing down a mountain, climbing a cliff, or mastering a new workout routine. In quieter moments, you’ll find him around a table playing board games or diving into a role-playing session—strategic hobbies that reveal his quick wit and knack for thinking on his feet. He even has a background in theater, where he once brought characters to life on stage, honing his ability to communicate and engage. Well-read and culturally curious, Peter is a person who values lifelong learning, whether it’s through books, experiences, or conversations. His diverse interests and skills reflect his belief that being a leader is about much more than business; it’s about understanding people, embracing new ideas, and staying open to what the world has to offer. This balance of professional drive and personal depth is what makes Peter not only a standout CEO but also an inspiring person to work with and learn from. In his role at Disruptive Pharma, Peter’s blend of scientific expertise, strategic mind, and broad outlook is exactly what the company needs as it continues to push the boundaries of innovation in healthcare. With Peter at the helm, Disruptive Pharma is positioned to make a real difference in the industry—and it’s clear that he’s only getting started.

Are you looking for instant or modified release options tailored to your therapeutic needs? Do you need complete dissolution in the GIT with no dose trapping or nutrient sequestering? Is achieving a high drug load a key priority for your formulation? Are you concerned about long-term amorphous and chemical stability? Could excellent flowability and tunable particle sizes simplify your tableting and capsule-filling processes? If these questions resonate, we’d love to talk. Connect with our CEO, Peter Åsberg or our Commercial Director, Sven Undeland at Bio-Europe to see how MMC can redefine your drug formulation solutions.

Excited to share that our CEO, Peter Åsberg & our director of process development, Marc Willuhn are attending CPHI Milan this year, marking the 35th anniversary of this premier global pharma event! As part of Disrupt Pharma, we are eager to showcase our innovative amorphous formulations, a breakthrough drug delivery technology made from a natural mineral. Our team will be on-site, ready to connect with industry leaders, innovators, and anyone interested in learning more about how our technology is enhancing bioavailability and stability in pharmaceuticals. Don't miss the chance to catch them at CPHI and explore potential collaborations! #CPHIMilan #PharmaInnovation #DrugDelivery #AmorphousFormulations #CPHI35 #CPHIChampions

Our CEO, Peter Åsberg will be attending the CPHI Worldwide Conference 2024 in Milan. This global event brings together over 60,000 attendees, 2,400+ exhibitors, and experts from 166+ countries to explore the latest innovations in the pharmaceutical industry. Peter will tell you all about Disruptive Pharma's Mesoporous Magnesium Carbonate (MMC) technology, a groundbreaking drug delivery platform that enhances API bioavailability, improves dissolution, and reduces inter-patient variability. MMC offers scalable, cost-effective solutions that streamline formulation development. Reach out at CPHI Milan to explore partnership opportunities and discover how MMC technology can enhance your pharmaceutical formulations.

Meet Tobias Assander (Lindholm) – Our expert in Process Development Tobias is a skilled professional with over a decade of experience in process development, particularly in projects involving new products, new processes, or new equipment. His expertise spans several industries, including pharmaceuticals and food production, where he has successfully scaled up complex manufacturing systems while maintaining high quality and compliance with GMP or other relevant standards. Tobias thrives in challenging environments where innovation is key. He has a proven ability to optimize processes, reduce costs, and ensure quality and regulatory compliance, often serving as a crucial link between engineering teams and chemists. His background includes various roles at companies like, Disruptive Materials, Barilla Group and Fresenius Kabi, where he handled everything from process development to tech transfer and project management, Interim supply manager & quality manager. On a personal level, Tobias values openness, honesty, and consistency in his work relationships. His long-term goal has always been to bridge the gap between technical teams and leadership, ensuring effective communication and smooth project execution. Tobias is not just about solving technical challenges; he brings a strategic mindset, always planning 3-5 years ahead to ensure sustainable growth. Outside of work, Tobias enjoys spending time with his family, including his 3.5-year-old daughter, Linnea, and staying active through running, cycling, and bandy, a passion since childhood. He is our star when it comes to leading complex development projects with a hands-on approach and a focus on quality, efficiency, and teamwork.

Introducing Disruptive Pharma’s MMC Technology

Tonight, we had the pleasure of attending LIFE PUB and gained valuable insights from Olink’s inspiring success story. Here are 4 key takeaways that truly stood out: ✅️ Succeeding in the US market? Move there! To establish a strong presence, Olink made the bold move to physically be where their biggest opportunities were. ✅️ Market penetration through services Olink introduced analysis services as a way to break into the market and add value to their offerings. A brilliant strategy to differentiate and scale. ✅️ Nothing for free! They maintained a strict “never for free” policy, reinforcing the value of their solutions from day one. ✅️ Know your competitors! Olink’s growth story includes always staying informed about competitors’ moves. Their awareness of the landscape gave them a critical edge.

Nordic lifescience days annual event is the largest life sciences partnering conference in the Nordic region, that attracts numerous industry leaders, investors, and innovators to discuss emerging trends, foster partnerships, and showcase developments in the field.This is an excellent platform for sharing innovation, gaining insights, and driving industry advancement. Of course our CEO, Peter Åsberg was present to represent Disruptive Pharma. If you have not yet get the chance to meet him reach out!

Our CEO, Peter Åsberg, will be attending the Nordic Life Science (NLS) Days. If you're interested in learning more about Disruptive Pharma's cutting-edge technology, this is a great opportunity to connect! Feel free to reach out to schedule a meeting and explore how we are pushing the boundaries of pharmaceutical innovation.

Mesoporous Magnesium Carbonate (MMC) enhances solubility, improves bioavailability, and reduces the need for excipients, making it the ideal solution for optimizing your drug formulations. Discover what MMC can do for your pharmaceutical development! #drugdevelopment #drugformulation #bioavailability #watersolubility #MMC #amorphization